A decrease in ABCA1-mediated reverse cholesterol efflux and impaired efferocytosis mediated by enhanced CD 47 expression over calreticulin can lead to progression of atherosclerosis lesions (Figure 5). Here, ABCA1 is linked to atherosclerosis.